Reactogenicity and Immunogenicity of the ChAdOx1 nCOV-19 Coronavirus Disease 2019 Vaccine in South Korean Healthcare Workers.

Yonsei Med J · 2022 · PMC9760890 · PMID 36444543

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Anti-SARS-CoV-2 S according to adverse event severity In local adverse events, the anti-SARS-CoV-2 S titer in swelling ( p =0.002) and itching ( p =0.036) after the first dose showed an increasing trend according to the grade of severity.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.